Swedish Drug Manufacturers—Specialty & Generic Industry Analysis

Benchmark and data visualization of Swedish public listed companies in the Drug Manufacturers—Specialty & Generic Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.

Sweden public listed companies in the Drug Manufacturers—Specialty & Generic industry: 11

Sweden Drug Manufacturers—Specialty & Generic total companies market cap (USD): $13.93 Billion

Top 10 Swedish Drug Manufacturers—Specialty & Generic Industry Companies Details as of July 1, 2024

Company	Market Cap (USD)	Country	Sector	Industry
Swedish Orphan Biovitrum AB	$8.73 B	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic
Karo Pharma AB	$1.49 B (Nov. 1, 2022)	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic
BioGaia AB	$1.18 B	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic
Calliditas Therapeutics AB (publ)	$1.05 B	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic
Swedencare AB	$700.8 M (July 1, 2025)	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic
Probi AB	$311.3 M	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic
EQL Pharma AB	$279.4 M (July 1, 2025)	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic
Oasmia Pharmaceutical AB	$76.7 M (June 1, 2022)	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic
Orexo AB	$66.0 M	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic
Enzymatica AB	$40.5 M	Sweden	Healthcare	Drug Manufacturers—Specialty & Generic